nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—CYP3A7—Ifosfamide—germ cell cancer	0.0899	0.238	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.0899	0.238	CbGbCtD
Ziprasidone—CYP3A5—Ifosfamide—germ cell cancer	0.0674	0.178	CbGbCtD
Ziprasidone—CYP3A5—Etoposide—germ cell cancer	0.0322	0.0852	CbGbCtD
Ziprasidone—CYP3A4—Ifosfamide—germ cell cancer	0.0263	0.0695	CbGbCtD
Ziprasidone—CYP1A2—Etoposide—germ cell cancer	0.024	0.0634	CbGbCtD
Ziprasidone—CYP2D6—Vinblastine—germ cell cancer	0.0219	0.058	CbGbCtD
Ziprasidone—CYP3A4—Vinblastine—germ cell cancer	0.0139	0.0369	CbGbCtD
Ziprasidone—CYP3A4—Etoposide—germ cell cancer	0.0126	0.0332	CbGbCtD
Ziprasidone—HTR2A—cranial nerve—germ cell cancer	0.00171	0.00553	CbGeAlD
Ziprasidone—HTR2A—pons—germ cell cancer	0.00169	0.00546	CbGeAlD
Ziprasidone—HTR1E—brainstem—germ cell cancer	0.00166	0.00535	CbGeAlD
Ziprasidone—SLC6A4—ganglion—germ cell cancer	0.00164	0.00529	CbGeAlD
Ziprasidone—CYP1A2—urine—germ cell cancer	0.00163	0.00525	CbGeAlD
Ziprasidone—HTR1E—telencephalon—germ cell cancer	0.00147	0.00474	CbGeAlD
Ziprasidone—HTR1A—ganglion—germ cell cancer	0.00146	0.00469	CbGeAlD
Ziprasidone—HTR1B—blood vessel—germ cell cancer	0.00143	0.00462	CbGeAlD
Ziprasidone—HTR2A—telencephalic ventricle—germ cell cancer	0.00139	0.00449	CbGeAlD
Ziprasidone—HTR7—ganglion—germ cell cancer	0.00139	0.00449	CbGeAlD
Ziprasidone—HTR1D—blood vessel—germ cell cancer	0.00139	0.00448	CbGeAlD
Ziprasidone—DRD2—ganglion—germ cell cancer	0.00132	0.00424	CbGeAlD
Ziprasidone—H1F0—neck—germ cell cancer	0.00128	0.00413	CbGeAlD
Ziprasidone—HTR2A—urine—germ cell cancer	0.00127	0.0041	CbGeAlD
Ziprasidone—HTR2A—appendage—germ cell cancer	0.00124	0.004	CbGeAlD
Ziprasidone—HTR2A—pineal body—germ cell cancer	0.00121	0.0039	CbGeAlD
Ziprasidone—HTR7—endothelium—germ cell cancer	0.0012	0.00387	CbGeAlD
Ziprasidone—CYP3A4—urine—germ cell cancer	0.00118	0.0038	CbGeAlD
Ziprasidone—CYP2D6—urine—germ cell cancer	0.00116	0.00374	CbGeAlD
Ziprasidone—HTR6—telencephalon—germ cell cancer	0.00115	0.00372	CbGeAlD
Ziprasidone—DRD5—telencephalon—germ cell cancer	0.00112	0.00362	CbGeAlD
Ziprasidone—H1F0—trigeminal ganglion—germ cell cancer	0.00111	0.00357	CbGeAlD
Ziprasidone—HTR7—blood vessel—germ cell cancer	0.00111	0.00357	CbGeAlD
Ziprasidone—CHRM5—eye—germ cell cancer	0.00111	0.00357	CbGeAlD
Ziprasidone—H1F0—embryo—germ cell cancer	0.00107	0.00345	CbGeAlD
Ziprasidone—HTR3A—trigeminal ganglion—germ cell cancer	0.00106	0.00341	CbGeAlD
Ziprasidone—DRD4—testis—germ cell cancer	0.00103	0.00331	CbGeAlD
Ziprasidone—HTR1E—female gonad—germ cell cancer	0.000998	0.00322	CbGeAlD
Ziprasidone—DRD1—brainstem—germ cell cancer	0.000968	0.00312	CbGeAlD
Ziprasidone—CHRM5—skin of body—germ cell cancer	0.000962	0.0031	CbGeAlD
Ziprasidone—H1F0—retina—germ cell cancer	0.000945	0.00305	CbGeAlD
Ziprasidone—HTR3A—brainstem—germ cell cancer	0.000934	0.00301	CbGeAlD
Ziprasidone—HTR1E—head—germ cell cancer	0.000916	0.00295	CbGeAlD
Ziprasidone—HTR1B—trigeminal ganglion—germ cell cancer	0.000886	0.00286	CbGeAlD
Ziprasidone—H1F0—telencephalon—germ cell cancer	0.00087	0.0028	CbGeAlD
Ziprasidone—HTR2A—ganglion—germ cell cancer	0.000867	0.0028	CbGeAlD
Ziprasidone—DRD1—telencephalon—germ cell cancer	0.000859	0.00277	CbGeAlD
Ziprasidone—HTR1D—trigeminal ganglion—germ cell cancer	0.000858	0.00277	CbGeAlD
Ziprasidone—H1F0—skin of body—germ cell cancer	0.00083	0.00268	CbGeAlD
Ziprasidone—HTR3A—telencephalon—germ cell cancer	0.000829	0.00267	CbGeAlD
Ziprasidone—H1F0—decidua—germ cell cancer	0.000824	0.00266	CbGeAlD
Ziprasidone—CHRM4—head—germ cell cancer	0.000803	0.00259	CbGeAlD
Ziprasidone—HTR7—neck—germ cell cancer	0.000791	0.00255	CbGeAlD
Ziprasidone—HTR1B—brainstem—germ cell cancer	0.000784	0.00253	CbGeAlD
Ziprasidone—CHRM4—testis—germ cell cancer	0.000776	0.0025	CbGeAlD
Ziprasidone—DRD4—brain—germ cell cancer	0.00077	0.00248	CbGeAlD
Ziprasidone—DRD5—female gonad—germ cell cancer	0.000762	0.00246	CbGeAlD
Ziprasidone—HTR1D—brainstem—germ cell cancer	0.000759	0.00245	CbGeAlD
Ziprasidone—HTR2C—brainstem—germ cell cancer	0.000752	0.00242	CbGeAlD
Ziprasidone—HTR2A—endothelium—germ cell cancer	0.000748	0.00241	CbGeAlD
Ziprasidone—DRD3—head—germ cell cancer	0.000747	0.00241	CbGeAlD
Ziprasidone—CYP3A7—endocrine gland—germ cell cancer	0.00074	0.00239	CbGeAlD
Ziprasidone—HTR1D—eye—germ cell cancer	0.000739	0.00238	CbGeAlD
Ziprasidone—H1F0—gonad—germ cell cancer	0.000726	0.00234	CbGeAlD
Ziprasidone—H1F0—uterus—germ cell cancer	0.000721	0.00232	CbGeAlD
Ziprasidone—HTR6—head—germ cell cancer	0.000719	0.00232	CbGeAlD
Ziprasidone—SLC6A4—brainstem—germ cell cancer	0.000713	0.0023	CbGeAlD
Ziprasidone—DRD5—endocrine gland—germ cell cancer	0.000709	0.00229	CbGeAlD
Ziprasidone—H1F0—pituitary gland—germ cell cancer	0.000708	0.00228	CbGeAlD
Ziprasidone—DRD5—head—germ cell cancer	0.0007	0.00226	CbGeAlD
Ziprasidone—HTR1B—telencephalon—germ cell cancer	0.000696	0.00224	CbGeAlD
Ziprasidone—CHRM2—telencephalon—germ cell cancer	0.000692	0.00223	CbGeAlD
Ziprasidone—HTR2A—blood vessel—germ cell cancer	0.00069	0.00222	CbGeAlD
Ziprasidone—H1F0—medulla oblongata—germ cell cancer	0.000683	0.0022	CbGeAlD
Ziprasidone—HTR1D—telencephalon—germ cell cancer	0.000674	0.00217	CbGeAlD
Ziprasidone—HTR2C—telencephalon—germ cell cancer	0.000667	0.00215	CbGeAlD
Ziprasidone—HTR1E—brain—germ cell cancer	0.000664	0.00214	CbGeAlD
Ziprasidone—KCNH2—trigeminal ganglion—germ cell cancer	0.000636	0.00205	CbGeAlD
Ziprasidone—HTR1A—brainstem—germ cell cancer	0.000633	0.00204	CbGeAlD
Ziprasidone—H1F0—adrenal gland—germ cell cancer	0.000633	0.00204	CbGeAlD
Ziprasidone—SLC6A4—telencephalon—germ cell cancer	0.000632	0.00204	CbGeAlD
Ziprasidone—CHRM1—telencephalon—germ cell cancer	0.00063	0.00203	CbGeAlD
Ziprasidone—ADRA2C—trigeminal ganglion—germ cell cancer	0.000628	0.00203	CbGeAlD
Ziprasidone—CHRM5—head—germ cell cancer	0.000628	0.00202	CbGeAlD
Ziprasidone—H1F0—midbrain—germ cell cancer	0.000624	0.00201	CbGeAlD
Ziprasidone—DRD1—midbrain—germ cell cancer	0.000617	0.00199	CbGeAlD
Ziprasidone—H1F0—bone marrow—germ cell cancer	0.000612	0.00197	CbGeAlD
Ziprasidone—H1F0—spinal cord—germ cell cancer	0.000609	0.00196	CbGeAlD
Ziprasidone—HTR7—brainstem—germ cell cancer	0.000605	0.00195	CbGeAlD
Ziprasidone—H1F0—female gonad—germ cell cancer	0.00059	0.0019	CbGeAlD
Ziprasidone—ADRA1A—brainstem—germ cell cancer	0.000583	0.00188	CbGeAlD
Ziprasidone—CHRM4—brain—germ cell cancer	0.000582	0.00188	CbGeAlD
Ziprasidone—ADRA1B—head—germ cell cancer	0.000574	0.00185	CbGeAlD
Ziprasidone—DRD2—brainstem—germ cell cancer	0.000572	0.00184	CbGeAlD
Ziprasidone—CHRM3—telencephalon—germ cell cancer	0.000564	0.00182	CbGeAlD
Ziprasidone—HTR1A—telencephalon—germ cell cancer	0.000561	0.00181	CbGeAlD
Ziprasidone—DRD2—eye—germ cell cancer	0.000557	0.00179	CbGeAlD
Ziprasidone—DRD2—retina—germ cell cancer	0.000552	0.00178	CbGeAlD
Ziprasidone—H1F0—endocrine gland—germ cell cancer	0.000548	0.00177	CbGeAlD
Ziprasidone—H1F0—head—germ cell cancer	0.000541	0.00175	CbGeAlD
Ziprasidone—DRD3—brain—germ cell cancer	0.000541	0.00174	CbGeAlD
Ziprasidone—HTR7—telencephalon—germ cell cancer	0.000537	0.00173	CbGeAlD
Ziprasidone—DRD1—head—germ cell cancer	0.000535	0.00172	CbGeAlD
Ziprasidone—HTR2C—medulla oblongata—germ cell cancer	0.000524	0.00169	CbGeAlD
Ziprasidone—H1F0—testis—germ cell cancer	0.000523	0.00169	CbGeAlD
Ziprasidone—HTR6—brain—germ cell cancer	0.000521	0.00168	CbGeAlD
Ziprasidone—ADRA1A—telencephalon—germ cell cancer	0.000518	0.00167	CbGeAlD
Ziprasidone—HTR3A—head—germ cell cancer	0.000516	0.00167	CbGeAlD
Ziprasidone—HRH1—trigeminal ganglion—germ cell cancer	0.00051	0.00165	CbGeAlD
Ziprasidone—DRD2—telencephalon—germ cell cancer	0.000507	0.00164	CbGeAlD
Ziprasidone—DRD5—brain—germ cell cancer	0.000507	0.00164	CbGeAlD
Ziprasidone—ADRA2A—trigeminal ganglion—germ cell cancer	0.000501	0.00162	CbGeAlD
Ziprasidone—KCNH2—telencephalon—germ cell cancer	0.0005	0.00161	CbGeAlD
Ziprasidone—HTR1B—midbrain—germ cell cancer	0.0005	0.00161	CbGeAlD
Ziprasidone—HTR2A—neck—germ cell cancer	0.000493	0.00159	CbGeAlD
Ziprasidone—ADRA2C—telencephalon—germ cell cancer	0.000493	0.00159	CbGeAlD
Ziprasidone—HTR1B—spinal cord—germ cell cancer	0.000487	0.00157	CbGeAlD
Ziprasidone—HTR1D—midbrain—germ cell cancer	0.000484	0.00156	CbGeAlD
Ziprasidone—H1F0—cerebellum—germ cell cancer	0.000483	0.00156	CbGeAlD
Ziprasidone—HTR2C—midbrain—germ cell cancer	0.000479	0.00154	CbGeAlD
Ziprasidone—ADRA2C—decidua—germ cell cancer	0.000467	0.00151	CbGeAlD
Ziprasidone—HTR2C—spinal cord—germ cell cancer	0.000467	0.00151	CbGeAlD
Ziprasidone—Agitation—Ifosfamide—germ cell cancer	0.000465	0.00164	CcSEcCtD
Ziprasidone—Angioedema—Ifosfamide—germ cell cancer	0.000463	0.00163	CcSEcCtD
Ziprasidone—Anorexia—Bleomycin—germ cell cancer	0.000461	0.00163	CcSEcCtD
Ziprasidone—Thrombophlebitis—Methotrexate—germ cell cancer	0.00046	0.00162	CcSEcCtD
Ziprasidone—Diabetes mellitus—Methotrexate—germ cell cancer	0.000457	0.00161	CcSEcCtD
Ziprasidone—Hypoaesthesia—Etoposide—germ cell cancer	0.000457	0.00161	CcSEcCtD
Ziprasidone—CHRM5—brain—germ cell cancer	0.000455	0.00147	CbGeAlD
Ziprasidone—Vertigo—Ifosfamide—germ cell cancer	0.000455	0.00161	CcSEcCtD
Ziprasidone—SLC6A4—midbrain—germ cell cancer	0.000454	0.00146	CbGeAlD
Ziprasidone—Urinary tract disorder—Etoposide—germ cell cancer	0.000454	0.0016	CcSEcCtD
Ziprasidone—Leukopenia—Ifosfamide—germ cell cancer	0.000453	0.0016	CcSEcCtD
Ziprasidone—Polyuria—Methotrexate—germ cell cancer	0.000453	0.0016	CcSEcCtD
Ziprasidone—Immune system disorder—Cisplatin—germ cell cancer	0.000453	0.0016	CcSEcCtD
Ziprasidone—Abdominal pain—Vinblastine—germ cell cancer	0.000453	0.0016	CcSEcCtD
Ziprasidone—Mediastinal disorder—Cisplatin—germ cell cancer	0.000452	0.0016	CcSEcCtD
Ziprasidone—Hypotension—Bleomycin—germ cell cancer	0.000452	0.0016	CcSEcCtD
Ziprasidone—Urethral disorder—Etoposide—germ cell cancer	0.00045	0.00159	CcSEcCtD
Ziprasidone—Infection—Dactinomycin—germ cell cancer	0.000448	0.00158	CcSEcCtD
Ziprasidone—Arrhythmia—Cisplatin—germ cell cancer	0.000448	0.00158	CcSEcCtD
Ziprasidone—HTR7—gonad—germ cell cancer	0.000448	0.00144	CbGeAlD
Ziprasidone—Palpitations—Ifosfamide—germ cell cancer	0.000447	0.00158	CcSEcCtD
Ziprasidone—Alopecia—Cisplatin—germ cell cancer	0.000443	0.00156	CcSEcCtD
Ziprasidone—SLC6A4—spinal cord—germ cell cancer	0.000443	0.00143	CbGeAlD
Ziprasidone—Cough—Ifosfamide—germ cell cancer	0.000442	0.00156	CcSEcCtD
Ziprasidone—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000442	0.00156	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000441	0.00156	CcSEcCtD
Ziprasidone—HRH1—eye—germ cell cancer	0.000439	0.00142	CbGeAlD
Ziprasidone—HTR1B—endocrine gland—germ cell cancer	0.000439	0.00142	CbGeAlD
Ziprasidone—Hypertension—Ifosfamide—germ cell cancer	0.000437	0.00154	CcSEcCtD
Ziprasidone—Erythema—Cisplatin—germ cell cancer	0.000437	0.00154	CcSEcCtD
Ziprasidone—Malnutrition—Cisplatin—germ cell cancer	0.000437	0.00154	CcSEcCtD
Ziprasidone—CHRM2—endocrine gland—germ cell cancer	0.000437	0.00141	CbGeAlD
Ziprasidone—Paraesthesia—Bleomycin—germ cell cancer	0.000434	0.00153	CcSEcCtD
Ziprasidone—HTR1B—head—germ cell cancer	0.000433	0.0014	CbGeAlD
Ziprasidone—Dyspnoea—Bleomycin—germ cell cancer	0.000431	0.00152	CcSEcCtD
Ziprasidone—Arthralgia—Ifosfamide—germ cell cancer	0.000431	0.00152	CcSEcCtD
Ziprasidone—Chest pain—Ifosfamide—germ cell cancer	0.000431	0.00152	CcSEcCtD
Ziprasidone—Myalgia—Ifosfamide—germ cell cancer	0.000431	0.00152	CcSEcCtD
Ziprasidone—CHRM2—head—germ cell cancer	0.000431	0.00139	CbGeAlD
Ziprasidone—Renal failure acute—Methotrexate—germ cell cancer	0.000431	0.00152	CcSEcCtD
Ziprasidone—Flatulence—Cisplatin—germ cell cancer	0.00043	0.00152	CcSEcCtD
Ziprasidone—Anorexia—Dactinomycin—germ cell cancer	0.00043	0.00152	CcSEcCtD
Ziprasidone—Eye disorder—Etoposide—germ cell cancer	0.000429	0.00152	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000428	0.00151	CcSEcCtD
Ziprasidone—Cardiac disorder—Etoposide—germ cell cancer	0.000426	0.00151	CcSEcCtD
Ziprasidone—Hypersensitivity—Vinblastine—germ cell cancer	0.000422	0.00149	CcSEcCtD
Ziprasidone—HTR7—medulla oblongata—germ cell cancer	0.000422	0.00136	CbGeAlD
Ziprasidone—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000422	0.00149	CcSEcCtD
Ziprasidone—Decreased appetite—Bleomycin—germ cell cancer	0.00042	0.00148	CcSEcCtD
Ziprasidone—Visual disturbance—Methotrexate—germ cell cancer	0.00042	0.00148	CcSEcCtD
Ziprasidone—Muscle spasms—Cisplatin—germ cell cancer	0.00042	0.00148	CcSEcCtD
Ziprasidone—HTR1D—head—germ cell cancer	0.000419	0.00135	CbGeAlD
Ziprasidone—Angiopathy—Etoposide—germ cell cancer	0.000417	0.00147	CcSEcCtD
Ziprasidone—Confusional state—Ifosfamide—germ cell cancer	0.000417	0.00147	CcSEcCtD
Ziprasidone—ADRA1B—brain—germ cell cancer	0.000416	0.00134	CbGeAlD
Ziprasidone—HTR2C—head—germ cell cancer	0.000415	0.00134	CbGeAlD
Ziprasidone—Immune system disorder—Etoposide—germ cell cancer	0.000415	0.00147	CcSEcCtD
Ziprasidone—KCNH2—uterus—germ cell cancer	0.000414	0.00134	CbGeAlD
Ziprasidone—Mediastinal disorder—Etoposide—germ cell cancer	0.000414	0.00146	CcSEcCtD
Ziprasidone—DRD2—pituitary gland—germ cell cancer	0.000413	0.00133	CbGeAlD
Ziprasidone—Chills—Etoposide—germ cell cancer	0.000412	0.00146	CcSEcCtD
Ziprasidone—HTR2A—embryo—germ cell cancer	0.000411	0.00133	CbGeAlD
Ziprasidone—Vision blurred—Cisplatin—germ cell cancer	0.000411	0.00145	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000411	0.00145	CcSEcCtD
Ziprasidone—Asthenia—Vinblastine—germ cell cancer	0.000411	0.00145	CcSEcCtD
Ziprasidone—Infection—Ifosfamide—germ cell cancer	0.000411	0.00145	CcSEcCtD
Ziprasidone—Tremor—Cisplatin—germ cell cancer	0.000409	0.00144	CcSEcCtD
Ziprasidone—ADRA2C—uterus—germ cell cancer	0.000409	0.00132	CbGeAlD
Ziprasidone—HTR1A—adrenal gland—germ cell cancer	0.000408	0.00132	CbGeAlD
Ziprasidone—KCNH2—pituitary gland—germ cell cancer	0.000407	0.00131	CbGeAlD
Ziprasidone—Alopecia—Etoposide—germ cell cancer	0.000406	0.00143	CcSEcCtD
Ziprasidone—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000406	0.00143	CcSEcCtD
Ziprasidone—Lethargy—Methotrexate—germ cell cancer	0.000406	0.00143	CcSEcCtD
Ziprasidone—Nervous system disorder—Ifosfamide—germ cell cancer	0.000405	0.00143	CcSEcCtD
Ziprasidone—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000405	0.00143	CcSEcCtD
Ziprasidone—Anaemia—Cisplatin—germ cell cancer	0.000403	0.00142	CcSEcCtD
Ziprasidone—HTR1A—midbrain—germ cell cancer	0.000403	0.0013	CbGeAlD
Ziprasidone—ADRA2C—pituitary gland—germ cell cancer	0.000402	0.00129	CbGeAlD
Ziprasidone—Skin disorder—Ifosfamide—germ cell cancer	0.000401	0.00142	CcSEcCtD
Ziprasidone—HRH1—telencephalon—germ cell cancer	0.000401	0.00129	CbGeAlD
Ziprasidone—Hyperhidrosis—Ifosfamide—germ cell cancer	0.0004	0.00141	CcSEcCtD
Ziprasidone—SLC6A4—endocrine gland—germ cell cancer	0.000399	0.00129	CbGeAlD
Ziprasidone—Feeling abnormal—Bleomycin—germ cell cancer	0.000398	0.00141	CcSEcCtD
Ziprasidone—Osteoarthritis—Methotrexate—germ cell cancer	0.000398	0.0014	CcSEcCtD
Ziprasidone—CHRM1—endocrine gland—germ cell cancer	0.000397	0.00128	CbGeAlD
Ziprasidone—Anorexia—Ifosfamide—germ cell cancer	0.000394	0.00139	CcSEcCtD
Ziprasidone—SLC6A4—head—germ cell cancer	0.000394	0.00127	CbGeAlD
Ziprasidone—ADRA2A—telencephalon—germ cell cancer	0.000394	0.00127	CbGeAlD
Ziprasidone—HTR1A—spinal cord—germ cell cancer	0.000393	0.00127	CbGeAlD
Ziprasidone—KCNH2—medulla oblongata—germ cell cancer	0.000393	0.00127	CbGeAlD
Ziprasidone—H1F0—brain—germ cell cancer	0.000392	0.00127	CbGeAlD
Ziprasidone—CHRM1—head—germ cell cancer	0.000392	0.00126	CbGeAlD
Ziprasidone—Decreased appetite—Dactinomycin—germ cell cancer	0.000392	0.00138	CcSEcCtD
Ziprasidone—Diarrhoea—Vinblastine—germ cell cancer	0.000392	0.00138	CcSEcCtD
Ziprasidone—Leukopenia—Cisplatin—germ cell cancer	0.000391	0.00138	CcSEcCtD
Ziprasidone—HTR7—adrenal gland—germ cell cancer	0.00039	0.00126	CbGeAlD
Ziprasidone—Fatigue—Dactinomycin—germ cell cancer	0.000389	0.00137	CcSEcCtD
Ziprasidone—ADRA2C—medulla oblongata—germ cell cancer	0.000388	0.00125	CbGeAlD
Ziprasidone—DRD1—brain—germ cell cancer	0.000387	0.00125	CbGeAlD
Ziprasidone—Back pain—Etoposide—germ cell cancer	0.000387	0.00137	CcSEcCtD
Ziprasidone—Hypotension—Ifosfamide—germ cell cancer	0.000386	0.00136	CcSEcCtD
Ziprasidone—HTR7—midbrain—germ cell cancer	0.000385	0.00124	CbGeAlD
Ziprasidone—Muscle spasms—Etoposide—germ cell cancer	0.000385	0.00136	CcSEcCtD
Ziprasidone—Urticaria—Bleomycin—germ cell cancer	0.000384	0.00136	CcSEcCtD
Ziprasidone—CHRM3—female gonad—germ cell cancer	0.000382	0.00123	CbGeAlD
Ziprasidone—Body temperature increased—Bleomycin—germ cell cancer	0.000382	0.00135	CcSEcCtD
Ziprasidone—HRH1—decidua—germ cell cancer	0.00038	0.00122	CbGeAlD
Ziprasidone—H1F0—lymph node—germ cell cancer	0.000379	0.00122	CbGeAlD
Ziprasidone—Dizziness—Vinblastine—germ cell cancer	0.000379	0.00134	CcSEcCtD
Ziprasidone—HTR2A—brainstem—germ cell cancer	0.000377	0.00122	CbGeAlD
Ziprasidone—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000377	0.00133	CcSEcCtD
Ziprasidone—ADRA1A—adrenal gland—germ cell cancer	0.000376	0.00121	CbGeAlD
Ziprasidone—HTR7—spinal cord—germ cell cancer	0.000376	0.00121	CbGeAlD
Ziprasidone—HTR3A—brain—germ cell cancer	0.000374	0.00121	CbGeAlD
Ziprasidone—Ataxia—Methotrexate—germ cell cancer	0.000374	0.00132	CcSEcCtD
Ziprasidone—ADRA2A—decidua—germ cell cancer	0.000373	0.0012	CbGeAlD
Ziprasidone—Myalgia—Cisplatin—germ cell cancer	0.000372	0.00131	CcSEcCtD
Ziprasidone—Feeling abnormal—Dactinomycin—germ cell cancer	0.000372	0.00131	CcSEcCtD
Ziprasidone—Paraesthesia—Ifosfamide—germ cell cancer	0.000371	0.00131	CcSEcCtD
Ziprasidone—Anxiety—Cisplatin—germ cell cancer	0.00037	0.00131	CcSEcCtD
Ziprasidone—Anaemia—Etoposide—germ cell cancer	0.00037	0.00131	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000369	0.0013	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000369	0.0013	CcSEcCtD
Ziprasidone—Dyspnoea—Ifosfamide—germ cell cancer	0.000368	0.0013	CcSEcCtD
Ziprasidone—Somnolence—Ifosfamide—germ cell cancer	0.000367	0.0013	CcSEcCtD
Ziprasidone—Liver function test abnormal—Methotrexate—germ cell cancer	0.000367	0.0013	CcSEcCtD
Ziprasidone—HTR2A—eye—germ cell cancer	0.000367	0.00118	CbGeAlD
Ziprasidone—DRD2—midbrain—germ cell cancer	0.000364	0.00117	CbGeAlD
Ziprasidone—Vomiting—Vinblastine—germ cell cancer	0.000364	0.00129	CcSEcCtD
Ziprasidone—HTR2A—retina—germ cell cancer	0.000364	0.00117	CbGeAlD
Ziprasidone—KCNH2—adrenal gland—germ cell cancer	0.000364	0.00117	CbGeAlD
Ziprasidone—Breast disorder—Methotrexate—germ cell cancer	0.000359	0.00127	CcSEcCtD
Ziprasidone—Vertigo—Etoposide—germ cell cancer	0.000359	0.00127	CcSEcCtD
Ziprasidone—Decreased appetite—Ifosfamide—germ cell cancer	0.000359	0.00127	CcSEcCtD
Ziprasidone—KCNH2—midbrain—germ cell cancer	0.000359	0.00116	CbGeAlD
Ziprasidone—ADRA2C—adrenal gland—germ cell cancer	0.000359	0.00116	CbGeAlD
Ziprasidone—Headache—Vinblastine—germ cell cancer	0.000359	0.00127	CcSEcCtD
Ziprasidone—Leukopenia—Etoposide—germ cell cancer	0.000358	0.00126	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000357	0.00126	CcSEcCtD
Ziprasidone—Body temperature increased—Dactinomycin—germ cell cancer	0.000357	0.00126	CcSEcCtD
Ziprasidone—Abdominal pain—Dactinomycin—germ cell cancer	0.000357	0.00126	CcSEcCtD
Ziprasidone—Fatigue—Ifosfamide—germ cell cancer	0.000356	0.00126	CcSEcCtD
Ziprasidone—Hypersensitivity—Bleomycin—germ cell cancer	0.000356	0.00126	CcSEcCtD
Ziprasidone—CHRM3—endocrine gland—germ cell cancer	0.000356	0.00115	CbGeAlD
Ziprasidone—ADRA2C—midbrain—germ cell cancer	0.000354	0.00114	CbGeAlD
Ziprasidone—HTR1A—endocrine gland—germ cell cancer	0.000354	0.00114	CbGeAlD
Ziprasidone—Infection—Cisplatin—germ cell cancer	0.000354	0.00125	CcSEcCtD
Ziprasidone—Constipation—Ifosfamide—germ cell cancer	0.000353	0.00125	CcSEcCtD
Ziprasidone—KCNH2—bone marrow—germ cell cancer	0.000352	0.00113	CbGeAlD
Ziprasidone—Loss of consciousness—Etoposide—germ cell cancer	0.000352	0.00124	CcSEcCtD
Ziprasidone—CHRM3—head—germ cell cancer	0.000351	0.00113	CbGeAlD
Ziprasidone—KCNH2—spinal cord—germ cell cancer	0.00035	0.00113	CbGeAlD
Ziprasidone—HTR1A—head—germ cell cancer	0.00035	0.00113	CbGeAlD
Ziprasidone—Nervous system disorder—Cisplatin—germ cell cancer	0.000349	0.00123	CcSEcCtD
Ziprasidone—Cough—Etoposide—germ cell cancer	0.000349	0.00123	CcSEcCtD
Ziprasidone—Thrombocytopenia—Cisplatin—germ cell cancer	0.000349	0.00123	CcSEcCtD
Ziprasidone—Tachycardia—Cisplatin—germ cell cancer	0.000348	0.00123	CcSEcCtD
Ziprasidone—Asthenia—Bleomycin—germ cell cancer	0.000347	0.00123	CcSEcCtD
Ziprasidone—Skin disorder—Cisplatin—germ cell cancer	0.000346	0.00122	CcSEcCtD
Ziprasidone—ADRA2C—spinal cord—germ cell cancer	0.000346	0.00111	CbGeAlD
Ziprasidone—Hypertension—Etoposide—germ cell cancer	0.000345	0.00122	CcSEcCtD
Ziprasidone—Hyperhidrosis—Cisplatin—germ cell cancer	0.000344	0.00122	CcSEcCtD
Ziprasidone—CYP2D6—brainstem—germ cell cancer	0.000343	0.00111	CbGeAlD
Ziprasidone—Feeling abnormal—Ifosfamide—germ cell cancer	0.000341	0.0012	CcSEcCtD
Ziprasidone—Chest pain—Etoposide—germ cell cancer	0.00034	0.0012	CcSEcCtD
Ziprasidone—Eosinophilia—Methotrexate—germ cell cancer	0.00034	0.0012	CcSEcCtD
Ziprasidone—Nausea—Vinblastine—germ cell cancer	0.00034	0.0012	CcSEcCtD
Ziprasidone—Anorexia—Cisplatin—germ cell cancer	0.00034	0.0012	CcSEcCtD
Ziprasidone—CHRM3—testis—germ cell cancer	0.000339	0.00109	CbGeAlD
Ziprasidone—KCNH2—female gonad—germ cell cancer	0.000339	0.00109	CbGeAlD
Ziprasidone—HTR7—endocrine gland—germ cell cancer	0.000338	0.00109	CbGeAlD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000338	0.00119	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000338	0.00119	CcSEcCtD
Ziprasidone—HTR2A—telencephalon—germ cell cancer	0.000335	0.00108	CbGeAlD
Ziprasidone—ADRA2C—female gonad—germ cell cancer	0.000334	0.00108	CbGeAlD
Ziprasidone—HTR7—head—germ cell cancer	0.000334	0.00108	CbGeAlD
Ziprasidone—Hypotension—Cisplatin—germ cell cancer	0.000333	0.00118	CcSEcCtD
Ziprasidone—Hypersensitivity—Dactinomycin—germ cell cancer	0.000332	0.00117	CcSEcCtD
Ziprasidone—Abdominal discomfort—Methotrexate—germ cell cancer	0.00033	0.00116	CcSEcCtD
Ziprasidone—Confusional state—Etoposide—germ cell cancer	0.000329	0.00116	CcSEcCtD
Ziprasidone—ADRA2A—gonad—germ cell cancer	0.000328	0.00106	CbGeAlD
Ziprasidone—Urticaria—Ifosfamide—germ cell cancer	0.000328	0.00116	CcSEcCtD
Ziprasidone—Body temperature increased—Ifosfamide—germ cell cancer	0.000327	0.00115	CcSEcCtD
Ziprasidone—Abdominal pain—Ifosfamide—germ cell cancer	0.000327	0.00115	CcSEcCtD
Ziprasidone—ADRA1A—endocrine gland—germ cell cancer	0.000326	0.00105	CbGeAlD
Ziprasidone—ADRA2A—uterus—germ cell cancer	0.000326	0.00105	CbGeAlD
Ziprasidone—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000325	0.00115	CcSEcCtD
Ziprasidone—Infection—Etoposide—germ cell cancer	0.000324	0.00114	CcSEcCtD
Ziprasidone—Asthenia—Dactinomycin—germ cell cancer	0.000324	0.00114	CcSEcCtD
Ziprasidone—HTR7—testis—germ cell cancer	0.000323	0.00104	CbGeAlD
Ziprasidone—ADRA1A—head—germ cell cancer	0.000322	0.00104	CbGeAlD
Ziprasidone—Dysuria—Methotrexate—germ cell cancer	0.000321	0.00114	CcSEcCtD
Ziprasidone—ADRA2A—pituitary gland—germ cell cancer	0.00032	0.00103	CbGeAlD
Ziprasidone—DRD2—endocrine gland—germ cell cancer	0.00032	0.00103	CbGeAlD
Ziprasidone—Paraesthesia—Cisplatin—germ cell cancer	0.00032	0.00113	CcSEcCtD
Ziprasidone—Thrombocytopenia—Etoposide—germ cell cancer	0.00032	0.00113	CcSEcCtD
Ziprasidone—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.00032	0.00113	CcSEcCtD
Ziprasidone—Tachycardia—Etoposide—germ cell cancer	0.000319	0.00112	CcSEcCtD
Ziprasidone—Dyspnoea—Cisplatin—germ cell cancer	0.000318	0.00112	CcSEcCtD
Ziprasidone—Skin disorder—Etoposide—germ cell cancer	0.000317	0.00112	CcSEcCtD
Ziprasidone—Erectile dysfunction—Methotrexate—germ cell cancer	0.000317	0.00112	CcSEcCtD
Ziprasidone—DRD2—head—germ cell cancer	0.000316	0.00102	CbGeAlD
Ziprasidone—Hyperhidrosis—Etoposide—germ cell cancer	0.000316	0.00111	CcSEcCtD
Ziprasidone—KCNH2—endocrine gland—germ cell cancer	0.000315	0.00102	CbGeAlD
Ziprasidone—HTR1B—brain—germ cell cancer	0.000314	0.00101	CbGeAlD
Ziprasidone—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000314	0.00111	CcSEcCtD
Ziprasidone—CHRM2—brain—germ cell cancer	0.000312	0.00101	CbGeAlD
Ziprasidone—HTR1A—cerebellum—germ cell cancer	0.000312	0.00101	CbGeAlD
Ziprasidone—KCNH2—head—germ cell cancer	0.000311	0.001	CbGeAlD
Ziprasidone—Anorexia—Etoposide—germ cell cancer	0.000311	0.0011	CcSEcCtD
Ziprasidone—Decreased appetite—Cisplatin—germ cell cancer	0.00031	0.00109	CcSEcCtD
Ziprasidone—ADRA2A—medulla oblongata—germ cell cancer	0.000309	0.000997	CbGeAlD
Ziprasidone—Diarrhoea—Dactinomycin—germ cell cancer	0.000309	0.00109	CcSEcCtD
Ziprasidone—Pneumonia—Methotrexate—germ cell cancer	0.000308	0.00109	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000308	0.00109	CcSEcCtD
Ziprasidone—Vomiting—Bleomycin—germ cell cancer	0.000307	0.00109	CcSEcCtD
Ziprasidone—ADRA2C—head—germ cell cancer	0.000307	0.00099	CbGeAlD
Ziprasidone—Infestation—Methotrexate—germ cell cancer	0.000307	0.00108	CcSEcCtD
Ziprasidone—Infestation NOS—Methotrexate—germ cell cancer	0.000307	0.00108	CcSEcCtD
Ziprasidone—DRD2—testis—germ cell cancer	0.000305	0.000984	CbGeAlD
Ziprasidone—Hypotension—Etoposide—germ cell cancer	0.000305	0.00108	CcSEcCtD
Ziprasidone—Rash—Bleomycin—germ cell cancer	0.000305	0.00108	CcSEcCtD
Ziprasidone—CYP2D6—telencephalon—germ cell cancer	0.000305	0.000983	CbGeAlD
Ziprasidone—Dermatitis—Bleomycin—germ cell cancer	0.000305	0.00108	CcSEcCtD
Ziprasidone—Hypersensitivity—Ifosfamide—germ cell cancer	0.000304	0.00108	CcSEcCtD
Ziprasidone—HTR1D—brain—germ cell cancer	0.000304	0.00098	CbGeAlD
Ziprasidone—Renal failure—Methotrexate—germ cell cancer	0.000301	0.00106	CcSEcCtD
Ziprasidone—HTR2C—brain—germ cell cancer	0.000301	0.000971	CbGeAlD
Ziprasidone—KCNH2—testis—germ cell cancer	0.000301	0.00097	CbGeAlD
Ziprasidone—HTR7—cerebellum—germ cell cancer	0.000298	0.000961	CbGeAlD
Ziprasidone—Conjunctivitis—Methotrexate—germ cell cancer	0.000298	0.00105	CcSEcCtD
Ziprasidone—ADRA2C—testis—germ cell cancer	0.000297	0.000957	CbGeAlD
Ziprasidone—Asthenia—Ifosfamide—germ cell cancer	0.000297	0.00105	CcSEcCtD
Ziprasidone—Sweating—Methotrexate—germ cell cancer	0.000294	0.00104	CcSEcCtD
Ziprasidone—Feeling abnormal—Cisplatin—germ cell cancer	0.000294	0.00104	CcSEcCtD
Ziprasidone—Paraesthesia—Etoposide—germ cell cancer	0.000293	0.00103	CcSEcCtD
Ziprasidone—Haematuria—Methotrexate—germ cell cancer	0.000292	0.00103	CcSEcCtD
Ziprasidone—HRH1—adrenal gland—germ cell cancer	0.000291	0.00094	CbGeAlD
Ziprasidone—Dyspnoea—Etoposide—germ cell cancer	0.000291	0.00103	CcSEcCtD
Ziprasidone—Somnolence—Etoposide—germ cell cancer	0.00029	0.00102	CcSEcCtD
Ziprasidone—Epistaxis—Methotrexate—germ cell cancer	0.000289	0.00102	CcSEcCtD
Ziprasidone—ADRA1A—cerebellum—germ cell cancer	0.000288	0.000927	CbGeAlD
Ziprasidone—Nausea—Bleomycin—germ cell cancer	0.000287	0.00101	CcSEcCtD
Ziprasidone—Vomiting—Dactinomycin—germ cell cancer	0.000287	0.00101	CcSEcCtD
Ziprasidone—ADRA2A—adrenal gland—germ cell cancer	0.000286	0.000923	CbGeAlD
Ziprasidone—SLC6A4—brain—germ cell cancer	0.000285	0.00092	CbGeAlD
Ziprasidone—Rash—Dactinomycin—germ cell cancer	0.000284	0.001	CcSEcCtD
Ziprasidone—CHRM1—brain—germ cell cancer	0.000284	0.000917	CbGeAlD
Ziprasidone—Decreased appetite—Etoposide—germ cell cancer	0.000284	0.001	CcSEcCtD
Ziprasidone—Diarrhoea—Ifosfamide—germ cell cancer	0.000283	0.000998	CcSEcCtD
Ziprasidone—ADRA2A—midbrain—germ cell cancer	0.000283	0.000911	CbGeAlD
Ziprasidone—DRD2—cerebellum—germ cell cancer	0.000282	0.000909	CbGeAlD
Ziprasidone—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000282	0.000995	CcSEcCtD
Ziprasidone—Body temperature increased—Cisplatin—germ cell cancer	0.000282	0.000995	CcSEcCtD
Ziprasidone—Fatigue—Etoposide—germ cell cancer	0.000281	0.000994	CcSEcCtD
Ziprasidone—CYP3A5—female gonad—germ cell cancer	0.00028	0.000903	CbGeAlD
Ziprasidone—HTR2A—gonad—germ cell cancer	0.000279	0.000901	CbGeAlD
Ziprasidone—Constipation—Etoposide—germ cell cancer	0.000279	0.000986	CcSEcCtD
Ziprasidone—KCNH2—cerebellum—germ cell cancer	0.000278	0.000895	CbGeAlD
Ziprasidone—Haemoglobin—Methotrexate—germ cell cancer	0.000277	0.000977	CcSEcCtD
Ziprasidone—ADRA2A—spinal cord—germ cell cancer	0.000276	0.000889	CbGeAlD
Ziprasidone—Haemorrhage—Methotrexate—germ cell cancer	0.000275	0.000972	CcSEcCtD
Ziprasidone—Hepatitis—Methotrexate—germ cell cancer	0.000275	0.000972	CcSEcCtD
Ziprasidone—ADRA2C—cerebellum—germ cell cancer	0.000274	0.000884	CbGeAlD
Ziprasidone—Dizziness—Ifosfamide—germ cell cancer	0.000273	0.000965	CcSEcCtD
Ziprasidone—Pharyngitis—Methotrexate—germ cell cancer	0.000273	0.000964	CcSEcCtD
Ziprasidone—HTR2A—pituitary gland—germ cell cancer	0.000272	0.000879	CbGeAlD
Ziprasidone—Urinary tract disorder—Methotrexate—germ cell cancer	0.000272	0.00096	CcSEcCtD
Ziprasidone—HRH1—female gonad—germ cell cancer	0.000272	0.000876	CbGeAlD
Ziprasidone—CYP1A2—endocrine gland—germ cell cancer	0.00027	0.00087	CbGeAlD
Ziprasidone—Urethral disorder—Methotrexate—germ cell cancer	0.00027	0.000953	CcSEcCtD
Ziprasidone—Feeling abnormal—Etoposide—germ cell cancer	0.000269	0.00095	CcSEcCtD
Ziprasidone—Nausea—Dactinomycin—germ cell cancer	0.000268	0.000946	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Etoposide—germ cell cancer	0.000267	0.000942	CcSEcCtD
Ziprasidone—ADRA2A—female gonad—germ cell cancer	0.000267	0.000861	CbGeAlD
Ziprasidone—Visual impairment—Methotrexate—germ cell cancer	0.000265	0.000936	CcSEcCtD
Ziprasidone—HTR2A—medulla oblongata—germ cell cancer	0.000263	0.000848	CbGeAlD
Ziprasidone—Vomiting—Ifosfamide—germ cell cancer	0.000263	0.000928	CcSEcCtD
Ziprasidone—Hypersensitivity—Cisplatin—germ cell cancer	0.000262	0.000927	CcSEcCtD
Ziprasidone—Rash—Ifosfamide—germ cell cancer	0.000261	0.00092	CcSEcCtD
Ziprasidone—CYP3A5—endocrine gland—germ cell cancer	0.00026	0.00084	CbGeAlD
Ziprasidone—Dermatitis—Ifosfamide—germ cell cancer	0.00026	0.000919	CcSEcCtD
Ziprasidone—Urticaria—Etoposide—germ cell cancer	0.000259	0.000916	CcSEcCtD
Ziprasidone—Abdominal pain—Etoposide—germ cell cancer	0.000258	0.000911	CcSEcCtD
Ziprasidone—Body temperature increased—Etoposide—germ cell cancer	0.000258	0.000911	CcSEcCtD
Ziprasidone—Eye disorder—Methotrexate—germ cell cancer	0.000257	0.000908	CcSEcCtD
Ziprasidone—Tinnitus—Methotrexate—germ cell cancer	0.000257	0.000906	CcSEcCtD
Ziprasidone—Asthenia—Cisplatin—germ cell cancer	0.000256	0.000903	CcSEcCtD
Ziprasidone—Cardiac disorder—Methotrexate—germ cell cancer	0.000255	0.000902	CcSEcCtD
Ziprasidone—CHRM3—brain—germ cell cancer	0.000254	0.00082	CbGeAlD
Ziprasidone—HTR1A—brain—germ cell cancer	0.000253	0.000817	CbGeAlD
Ziprasidone—HRH1—endocrine gland—germ cell cancer	0.000253	0.000815	CbGeAlD
Ziprasidone—Angiopathy—Methotrexate—germ cell cancer	0.00025	0.000882	CcSEcCtD
Ziprasidone—HRH1—head—germ cell cancer	0.000249	0.000804	CbGeAlD
Ziprasidone—Immune system disorder—Methotrexate—germ cell cancer	0.000249	0.000878	CcSEcCtD
Ziprasidone—ADRA2A—endocrine gland—germ cell cancer	0.000248	0.0008	CbGeAlD
Ziprasidone—Mediastinal disorder—Methotrexate—germ cell cancer	0.000248	0.000876	CcSEcCtD
Ziprasidone—Chills—Methotrexate—germ cell cancer	0.000247	0.000872	CcSEcCtD
Ziprasidone—Nausea—Ifosfamide—germ cell cancer	0.000245	0.000867	CcSEcCtD
Ziprasidone—ADRA2A—head—germ cell cancer	0.000245	0.00079	CbGeAlD
Ziprasidone—Diarrhoea—Cisplatin—germ cell cancer	0.000244	0.000861	CcSEcCtD
Ziprasidone—HTR2A—adrenal gland—germ cell cancer	0.000243	0.000785	CbGeAlD
Ziprasidone—Alopecia—Methotrexate—germ cell cancer	0.000243	0.000859	CcSEcCtD
Ziprasidone—HTR7—brain—germ cell cancer	0.000242	0.000781	CbGeAlD
Ziprasidone—Mental disorder—Methotrexate—germ cell cancer	0.000241	0.000851	CcSEcCtD
Ziprasidone—HRH1—testis—germ cell cancer	0.000241	0.000777	CbGeAlD
Ziprasidone—Hypersensitivity—Etoposide—germ cell cancer	0.00024	0.000849	CcSEcCtD
Ziprasidone—HTR2A—midbrain—germ cell cancer	0.00024	0.000775	CbGeAlD
Ziprasidone—Malnutrition—Methotrexate—germ cell cancer	0.00024	0.000846	CcSEcCtD
Ziprasidone—Erythema—Methotrexate—germ cell cancer	0.00024	0.000846	CcSEcCtD
Ziprasidone—ADRA2A—testis—germ cell cancer	0.000237	0.000763	CbGeAlD
Ziprasidone—HTR2A—spinal cord—germ cell cancer	0.000234	0.000756	CbGeAlD
Ziprasidone—Asthenia—Etoposide—germ cell cancer	0.000234	0.000827	CcSEcCtD
Ziprasidone—ADRA1A—brain—germ cell cancer	0.000234	0.000753	CbGeAlD
Ziprasidone—Back pain—Methotrexate—germ cell cancer	0.000232	0.000818	CcSEcCtD
Ziprasidone—DRD2—brain—germ cell cancer	0.000229	0.000738	CbGeAlD
Ziprasidone—Vomiting—Cisplatin—germ cell cancer	0.000227	0.0008	CcSEcCtD
Ziprasidone—Vision blurred—Methotrexate—germ cell cancer	0.000226	0.000797	CcSEcCtD
Ziprasidone—KCNH2—brain—germ cell cancer	0.000226	0.000727	CbGeAlD
Ziprasidone—Rash—Cisplatin—germ cell cancer	0.000225	0.000793	CcSEcCtD
Ziprasidone—Dermatitis—Cisplatin—germ cell cancer	0.000224	0.000792	CcSEcCtD
Ziprasidone—Diarrhoea—Etoposide—germ cell cancer	0.000223	0.000789	CcSEcCtD
Ziprasidone—ADRA2C—brain—germ cell cancer	0.000223	0.000718	CbGeAlD
Ziprasidone—Anaemia—Methotrexate—germ cell cancer	0.000221	0.000782	CcSEcCtD
Ziprasidone—ADRA2A—cerebellum—germ cell cancer	0.000219	0.000705	CbGeAlD
Ziprasidone—KCNH2—lymph node—germ cell cancer	0.000218	0.000703	CbGeAlD
Ziprasidone—Dizziness—Etoposide—germ cell cancer	0.000216	0.000762	CcSEcCtD
Ziprasidone—Vertigo—Methotrexate—germ cell cancer	0.000215	0.00076	CcSEcCtD
Ziprasidone—ADRA2C—lymph node—germ cell cancer	0.000215	0.000693	CbGeAlD
Ziprasidone—Leukopenia—Methotrexate—germ cell cancer	0.000214	0.000757	CcSEcCtD
Ziprasidone—Nausea—Cisplatin—germ cell cancer	0.000212	0.000747	CcSEcCtD
Ziprasidone—HTR2A—endocrine gland—germ cell cancer	0.000211	0.000681	CbGeAlD
Ziprasidone—Cough—Methotrexate—germ cell cancer	0.000209	0.000738	CcSEcCtD
Ziprasidone—HTR2A—head—germ cell cancer	0.000208	0.000672	CbGeAlD
Ziprasidone—Vomiting—Etoposide—germ cell cancer	0.000208	0.000733	CcSEcCtD
Ziprasidone—CYP2D6—female gonad—germ cell cancer	0.000207	0.000667	CbGeAlD
Ziprasidone—Rash—Etoposide—germ cell cancer	0.000206	0.000727	CcSEcCtD
Ziprasidone—Dermatitis—Etoposide—germ cell cancer	0.000206	0.000726	CcSEcCtD
Ziprasidone—Headache—Etoposide—germ cell cancer	0.000204	0.000722	CcSEcCtD
Ziprasidone—Arthralgia—Methotrexate—germ cell cancer	0.000204	0.00072	CcSEcCtD
Ziprasidone—Chest pain—Methotrexate—germ cell cancer	0.000204	0.00072	CcSEcCtD
Ziprasidone—Myalgia—Methotrexate—germ cell cancer	0.000204	0.00072	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000203	0.000715	CcSEcCtD
Ziprasidone—HTR2A—testis—germ cell cancer	0.000201	0.000649	CbGeAlD
Ziprasidone—Confusional state—Methotrexate—germ cell cancer	0.000197	0.000696	CcSEcCtD
Ziprasidone—CYP3A4—endocrine gland—germ cell cancer	0.000195	0.00063	CbGeAlD
Ziprasidone—Infection—Methotrexate—germ cell cancer	0.000194	0.000686	CcSEcCtD
Ziprasidone—Nausea—Etoposide—germ cell cancer	0.000194	0.000685	CcSEcCtD
Ziprasidone—CYP2D6—endocrine gland—germ cell cancer	0.000192	0.00062	CbGeAlD
Ziprasidone—Nervous system disorder—Methotrexate—germ cell cancer	0.000192	0.000677	CcSEcCtD
Ziprasidone—Thrombocytopenia—Methotrexate—germ cell cancer	0.000191	0.000676	CcSEcCtD
Ziprasidone—Skin disorder—Methotrexate—germ cell cancer	0.00019	0.000671	CcSEcCtD
Ziprasidone—CYP2D6—head—germ cell cancer	0.00019	0.000612	CbGeAlD
Ziprasidone—Hyperhidrosis—Methotrexate—germ cell cancer	0.000189	0.000667	CcSEcCtD
Ziprasidone—Anorexia—Methotrexate—germ cell cancer	0.000186	0.000658	CcSEcCtD
Ziprasidone—HTR2A—cerebellum—germ cell cancer	0.000186	0.000599	CbGeAlD
Ziprasidone—CYP2D6—testis—germ cell cancer	0.000183	0.000591	CbGeAlD
Ziprasidone—Hypotension—Methotrexate—germ cell cancer	0.000183	0.000645	CcSEcCtD
Ziprasidone—HRH1—brain—germ cell cancer	0.000181	0.000583	CbGeAlD
Ziprasidone—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000178	0.000629	CcSEcCtD
Ziprasidone—ADRA2A—brain—germ cell cancer	0.000178	0.000573	CbGeAlD
Ziprasidone—Insomnia—Methotrexate—germ cell cancer	0.000177	0.000624	CcSEcCtD
Ziprasidone—Paraesthesia—Methotrexate—germ cell cancer	0.000176	0.00062	CcSEcCtD
Ziprasidone—HRH1—lymph node—germ cell cancer	0.000175	0.000563	CbGeAlD
Ziprasidone—Dyspnoea—Methotrexate—germ cell cancer	0.000174	0.000615	CcSEcCtD
Ziprasidone—Somnolence—Methotrexate—germ cell cancer	0.000174	0.000614	CcSEcCtD
Ziprasidone—Dyspepsia—Methotrexate—germ cell cancer	0.000172	0.000608	CcSEcCtD
Ziprasidone—ADRA2A—lymph node—germ cell cancer	0.000172	0.000553	CbGeAlD
Ziprasidone—Decreased appetite—Methotrexate—germ cell cancer	0.00017	0.0006	CcSEcCtD
Ziprasidone—CYP2D6—cerebellum—germ cell cancer	0.000169	0.000546	CbGeAlD
Ziprasidone—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000169	0.000596	CcSEcCtD
Ziprasidone—Fatigue—Methotrexate—germ cell cancer	0.000169	0.000595	CcSEcCtD
Ziprasidone—Feeling abnormal—Methotrexate—germ cell cancer	0.000161	0.000569	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00016	0.000565	CcSEcCtD
Ziprasidone—Urticaria—Methotrexate—germ cell cancer	0.000155	0.000548	CcSEcCtD
Ziprasidone—Abdominal pain—Methotrexate—germ cell cancer	0.000155	0.000546	CcSEcCtD
Ziprasidone—Body temperature increased—Methotrexate—germ cell cancer	0.000155	0.000546	CcSEcCtD
Ziprasidone—HTR2A—brain—germ cell cancer	0.000151	0.000487	CbGeAlD
Ziprasidone—Hypersensitivity—Methotrexate—germ cell cancer	0.000144	0.000509	CcSEcCtD
Ziprasidone—Asthenia—Methotrexate—germ cell cancer	0.00014	0.000495	CcSEcCtD
Ziprasidone—CYP2D6—brain—germ cell cancer	0.000138	0.000444	CbGeAlD
Ziprasidone—Diarrhoea—Methotrexate—germ cell cancer	0.000134	0.000472	CcSEcCtD
Ziprasidone—Dizziness—Methotrexate—germ cell cancer	0.000129	0.000457	CcSEcCtD
Ziprasidone—Vomiting—Methotrexate—germ cell cancer	0.000124	0.000439	CcSEcCtD
Ziprasidone—Rash—Methotrexate—germ cell cancer	0.000123	0.000435	CcSEcCtD
Ziprasidone—Dermatitis—Methotrexate—germ cell cancer	0.000123	0.000435	CcSEcCtD
Ziprasidone—Headache—Methotrexate—germ cell cancer	0.000122	0.000432	CcSEcCtD
Ziprasidone—Nausea—Methotrexate—germ cell cancer	0.000116	0.00041	CcSEcCtD
Ziprasidone—HTR2C—Signaling Pathways—OXT—germ cell cancer	1.43e-05	0.0005	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—AVP—germ cell cancer	1.43e-05	0.0005	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—FGF4—germ cell cancer	1.43e-05	0.000499	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—H2AFZ—germ cell cancer	1.41e-05	0.000495	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—AVP—germ cell cancer	1.41e-05	0.000495	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—AVP—germ cell cancer	1.41e-05	0.000493	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—FGF4—germ cell cancer	1.41e-05	0.000492	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—H2AFZ—germ cell cancer	1.4e-05	0.000488	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—OXT—germ cell cancer	1.39e-05	0.000486	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—OXT—germ cell cancer	1.37e-05	0.000479	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—KITLG—germ cell cancer	1.36e-05	0.000476	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—KITLG—germ cell cancer	1.36e-05	0.000476	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—KIT—germ cell cancer	1.36e-05	0.000476	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—KITLG—germ cell cancer	1.35e-05	0.000473	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—H2AFZ—germ cell cancer	1.34e-05	0.000468	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—AVP—germ cell cancer	1.33e-05	0.000465	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—AVP—germ cell cancer	1.33e-05	0.000465	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—KITLG—germ cell cancer	1.32e-05	0.000463	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—AVP—germ cell cancer	1.32e-05	0.000462	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—FGFR3—germ cell cancer	1.31e-05	0.000459	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—AVP—germ cell cancer	1.31e-05	0.000458	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—SLC2A3—germ cell cancer	1.31e-05	0.000458	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—KITLG—germ cell cancer	1.3e-05	0.000455	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—AVP—germ cell cancer	1.29e-05	0.000452	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—SLC22A3—germ cell cancer	1.29e-05	0.000451	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—KITLG—germ cell cancer	1.28e-05	0.000449	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—H2AFZ—germ cell cancer	1.27e-05	0.000446	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—AVP—germ cell cancer	1.27e-05	0.000445	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—FGF4—germ cell cancer	1.27e-05	0.000444	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—OXT—germ cell cancer	1.26e-05	0.000441	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—H2AFZ—germ cell cancer	1.26e-05	0.00044	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—AVP—germ cell cancer	1.25e-05	0.000439	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—OXT—germ cell cancer	1.24e-05	0.000434	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—OXT—germ cell cancer	1.24e-05	0.000433	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—OXT—germ cell cancer	1.23e-05	0.000432	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—OXT—germ cell cancer	1.23e-05	0.000431	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—KITLG—germ cell cancer	1.23e-05	0.00043	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—FGF4—germ cell cancer	1.23e-05	0.000429	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—FGF4—germ cell cancer	1.22e-05	0.000427	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—OXT—germ cell cancer	1.22e-05	0.000426	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—OXT—germ cell cancer	1.22e-05	0.000425	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—KIT—germ cell cancer	1.2e-05	0.000421	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—AVP—germ cell cancer	1.2e-05	0.00042	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—FGF4—germ cell cancer	1.19e-05	0.000415	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—KITLG—germ cell cancer	1.17e-05	0.00041	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—FGF4—germ cell cancer	1.17e-05	0.000409	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—KITLG—germ cell cancer	1.16e-05	0.000404	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—AVP—germ cell cancer	1.14e-05	0.000401	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—H2AFZ—germ cell cancer	1.13e-05	0.000397	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—AVP—germ cell cancer	1.13e-05	0.000395	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—OXT—germ cell cancer	1.13e-05	0.000395	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—SLC2A3—germ cell cancer	1.11e-05	0.000388	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—H2AFZ—germ cell cancer	1.09e-05	0.000383	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—SLC22A3—germ cell cancer	1.09e-05	0.000382	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—H2AFZ—germ cell cancer	1.09e-05	0.000381	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—FGF4—germ cell cancer	1.08e-05	0.000377	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—H2AFZ—germ cell cancer	1.06e-05	0.000371	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—FGF4—germ cell cancer	1.06e-05	0.000371	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—FGF4—germ cell cancer	1.06e-05	0.00037	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—FGF4—germ cell cancer	1.05e-05	0.000369	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—FGF4—germ cell cancer	1.05e-05	0.000368	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—CRABP1—germ cell cancer	1.05e-05	0.000367	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—KITLG—germ cell cancer	1.04e-05	0.000365	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—H2AFZ—germ cell cancer	1.04e-05	0.000365	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—FGF4—germ cell cancer	1.04e-05	0.000364	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—FGF4—germ cell cancer	1.04e-05	0.000363	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—AVP—germ cell cancer	1.02e-05	0.000357	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—FGFR3—germ cell cancer	1.01e-05	0.000354	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—FGFR3—germ cell cancer	1.01e-05	0.000354	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—KITLG—germ cell cancer	1.01e-05	0.000353	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—FGFR3—germ cell cancer	1e-05	0.000351	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—KITLG—germ cell cancer	1e-05	0.000351	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling by GPCR—HRAS—germ cell cancer	9.94e-06	0.000348	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—AVP—germ cell cancer	9.85e-06	0.000345	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—FGFR3—germ cell cancer	9.83e-06	0.000344	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—AVP—germ cell cancer	9.79e-06	0.000343	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—KITLG—germ cell cancer	9.75e-06	0.000341	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—FGFR3—germ cell cancer	9.67e-06	0.000338	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—FGF4—germ cell cancer	9.64e-06	0.000337	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—H2AFZ—germ cell cancer	9.61e-06	0.000336	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—KITLG—germ cell cancer	9.59e-06	0.000336	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—FGFR3—germ cell cancer	9.54e-06	0.000334	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—AVP—germ cell cancer	9.53e-06	0.000333	CbGpPWpGaD
Ziprasidone—ADRA2B—Hemostasis—TP53—germ cell cancer	9.49e-06	0.000332	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—H2AFZ—germ cell cancer	9.46e-06	0.000331	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—H2AFZ—germ cell cancer	9.44e-06	0.00033	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—H2AFZ—germ cell cancer	9.41e-06	0.000329	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—H2AFZ—germ cell cancer	9.38e-06	0.000328	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—AVP—germ cell cancer	9.38e-06	0.000328	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—H2AFZ—germ cell cancer	9.29e-06	0.000325	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—KIT—germ cell cancer	9.29e-06	0.000325	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—KIT—germ cell cancer	9.28e-06	0.000325	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—H2AFZ—germ cell cancer	9.26e-06	0.000324	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—KIT—germ cell cancer	9.21e-06	0.000322	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—FGFR3—germ cell cancer	9.14e-06	0.00032	CbGpPWpGaD
Ziprasidone—ADRA2B—Hemostasis—HRAS—germ cell cancer	9.08e-06	0.000318	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—KIT—germ cell cancer	9.02e-06	0.000316	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CRABP1—germ cell cancer	8.89e-06	0.000311	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—KIT—germ cell cancer	8.88e-06	0.000311	CbGpPWpGaD
Ziprasidone—ADRA2C—Hemostasis—TP53—germ cell cancer	8.86e-06	0.00031	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—KITLG—germ cell cancer	8.84e-06	0.00031	CbGpPWpGaD
Ziprasidone—DRD5—Signaling by GPCR—HRAS—germ cell cancer	8.8e-06	0.000308	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—KIT—germ cell cancer	8.76e-06	0.000307	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—FGFR3—germ cell cancer	8.71e-06	0.000305	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—KITLG—germ cell cancer	8.7e-06	0.000305	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—KITLG—germ cell cancer	8.68e-06	0.000304	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—KITLG—germ cell cancer	8.66e-06	0.000303	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—AVP—germ cell cancer	8.64e-06	0.000303	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—KITLG—germ cell cancer	8.63e-06	0.000302	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—H2AFZ—germ cell cancer	8.61e-06	0.000301	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—FGFR3—germ cell cancer	8.59e-06	0.000301	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—SLC2A3—germ cell cancer	8.55e-06	0.000299	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—KITLG—germ cell cancer	8.54e-06	0.000299	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—KITLG—germ cell cancer	8.52e-06	0.000298	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—AVP—germ cell cancer	8.51e-06	0.000298	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—AVP—germ cell cancer	8.49e-06	0.000297	CbGpPWpGaD
Ziprasidone—ADRA2C—Hemostasis—HRAS—germ cell cancer	8.48e-06	0.000297	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—AVP—germ cell cancer	8.46e-06	0.000296	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—AVP—germ cell cancer	8.43e-06	0.000295	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—SLC22A3—germ cell cancer	8.42e-06	0.000295	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—KIT—germ cell cancer	8.39e-06	0.000294	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—AVP—germ cell cancer	8.35e-06	0.000292	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—AVP—germ cell cancer	8.33e-06	0.000291	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—KIT—germ cell cancer	7.99e-06	0.00028	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—KITLG—germ cell cancer	7.92e-06	0.000277	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—KIT—germ cell cancer	7.89e-06	0.000276	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—FGFR3—germ cell cancer	7.76e-06	0.000271	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—AVP—germ cell cancer	7.74e-06	0.000271	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—FGFR3—germ cell cancer	7.49e-06	0.000262	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—MYC—germ cell cancer	7.48e-06	0.000262	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—FGFR3—germ cell cancer	7.45e-06	0.000261	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—FGFR3—germ cell cancer	7.24e-06	0.000254	CbGpPWpGaD
Ziprasidone—ADRA2A—Hemostasis—TP53—germ cell cancer	7.2e-06	0.000252	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—FGFR3—germ cell cancer	7.13e-06	0.000249	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—KIT—germ cell cancer	7.12e-06	0.000249	CbGpPWpGaD
Ziprasidone—ADRA2A—Hemostasis—HRAS—germ cell cancer	6.89e-06	0.000241	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—KIT—germ cell cancer	6.87e-06	0.000241	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CRABP1—germ cell cancer	6.86e-06	0.00024	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—KIT—germ cell cancer	6.84e-06	0.000239	CbGpPWpGaD
Ziprasidone—HTR6—Signaling by GPCR—HRAS—germ cell cancer	6.79e-06	0.000238	CbGpPWpGaD
Ziprasidone—HTR7—Signaling by GPCR—HRAS—germ cell cancer	6.79e-06	0.000237	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling by GPCR—HRAS—germ cell cancer	6.74e-06	0.000236	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—KIT—germ cell cancer	6.65e-06	0.000233	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—MYC—germ cell cancer	6.62e-06	0.000232	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling by GPCR—HRAS—germ cell cancer	6.6e-06	0.000231	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—FGFR3—germ cell cancer	6.57e-06	0.00023	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—KIT—germ cell cancer	6.55e-06	0.000229	CbGpPWpGaD
Ziprasidone—DRD4—Signaling by GPCR—HRAS—germ cell cancer	6.5e-06	0.000227	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—FGFR3—germ cell cancer	6.47e-06	0.000226	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—FGFR3—germ cell cancer	6.45e-06	0.000226	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—FGFR3—germ cell cancer	6.43e-06	0.000225	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—FGFR3—germ cell cancer	6.41e-06	0.000224	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling by GPCR—HRAS—germ cell cancer	6.41e-06	0.000224	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—FGFR3—germ cell cancer	6.35e-06	0.000222	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—FGFR3—germ cell cancer	6.33e-06	0.000222	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—TP53—germ cell cancer	6.14e-06	0.000215	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—HRAS—germ cell cancer	6.14e-06	0.000215	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—KIT—germ cell cancer	6.03e-06	0.000211	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—KIT—germ cell cancer	5.94e-06	0.000208	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—KIT—germ cell cancer	5.93e-06	0.000207	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—KIT—germ cell cancer	5.91e-06	0.000207	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—KIT—germ cell cancer	5.89e-06	0.000206	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—FGFR3—germ cell cancer	5.88e-06	0.000206	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—HRAS—germ cell cancer	5.87e-06	0.000206	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—HRAS—germ cell cancer	5.85e-06	0.000205	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—KIT—germ cell cancer	5.83e-06	0.000204	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—KIT—germ cell cancer	5.81e-06	0.000203	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—HRAS—germ cell cancer	5.77e-06	0.000202	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—TP53—germ cell cancer	5.44e-06	0.00019	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—KIT—germ cell cancer	5.4e-06	0.000189	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—HRAS—germ cell cancer	5.21e-06	0.000182	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—HRAS—germ cell cancer	5.2e-06	0.000182	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—MYC—germ cell cancer	5.11e-06	0.000179	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—MYC—germ cell cancer	5.1e-06	0.000179	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—MYC—germ cell cancer	5.07e-06	0.000177	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—HRAS—germ cell cancer	5.03e-06	0.000176	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—HRAS—germ cell cancer	5e-06	0.000175	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—MYC—germ cell cancer	4.96e-06	0.000174	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—MYC—germ cell cancer	4.89e-06	0.000171	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—HRAS—germ cell cancer	4.87e-06	0.00017	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—MYC—germ cell cancer	4.82e-06	0.000169	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—HRAS—germ cell cancer	4.79e-06	0.000168	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—MYC—germ cell cancer	4.62e-06	0.000162	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—HRAS—germ cell cancer	4.41e-06	0.000155	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—MYC—germ cell cancer	4.4e-06	0.000154	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—HRAS—germ cell cancer	4.34e-06	0.000152	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—MYC—germ cell cancer	4.34e-06	0.000152	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—HRAS—germ cell cancer	4.33e-06	0.000152	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—HRAS—germ cell cancer	4.32e-06	0.000151	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—HRAS—germ cell cancer	4.31e-06	0.000151	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—HRAS—germ cell cancer	4.27e-06	0.000149	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—HRAS—germ cell cancer	4.25e-06	0.000149	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—TP53—germ cell cancer	4.2e-06	0.000147	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—TP53—germ cell cancer	4.19e-06	0.000147	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—TP53—germ cell cancer	4.16e-06	0.000146	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TP53—germ cell cancer	4.08e-06	0.000143	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—HRAS—germ cell cancer	4.01e-06	0.00014	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TP53—germ cell cancer	4.01e-06	0.00014	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—HRAS—germ cell cancer	4.01e-06	0.00014	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—HRAS—germ cell cancer	3.98e-06	0.000139	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TP53—germ cell cancer	3.96e-06	0.000139	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—HRAS—germ cell cancer	3.95e-06	0.000138	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MYC—germ cell cancer	3.92e-06	0.000137	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—HRAS—germ cell cancer	3.9e-06	0.000136	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—HRAS—germ cell cancer	3.84e-06	0.000134	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TP53—germ cell cancer	3.79e-06	0.000133	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—HRAS—germ cell cancer	3.79e-06	0.000132	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MYC—germ cell cancer	3.78e-06	0.000132	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MYC—germ cell cancer	3.76e-06	0.000132	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MYC—germ cell cancer	3.66e-06	0.000128	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—HRAS—germ cell cancer	3.63e-06	0.000127	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TP53—germ cell cancer	3.61e-06	0.000126	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MYC—germ cell cancer	3.6e-06	0.000126	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TP53—germ cell cancer	3.56e-06	0.000125	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—HRAS—germ cell cancer	3.45e-06	0.000121	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—HRAS—germ cell cancer	3.41e-06	0.000119	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MYC—germ cell cancer	3.32e-06	0.000116	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MYC—germ cell cancer	3.27e-06	0.000114	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MYC—germ cell cancer	3.26e-06	0.000114	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MYC—germ cell cancer	3.25e-06	0.000114	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MYC—germ cell cancer	3.24e-06	0.000113	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TP53—germ cell cancer	3.22e-06	0.000113	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MYC—germ cell cancer	3.21e-06	0.000112	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MYC—germ cell cancer	3.2e-06	0.000112	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TP53—germ cell cancer	3.11e-06	0.000109	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TP53—germ cell cancer	3.09e-06	0.000108	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—HRAS—germ cell cancer	3.08e-06	0.000108	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TP53—germ cell cancer	3.01e-06	0.000105	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MYC—germ cell cancer	2.97e-06	0.000104	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—HRAS—germ cell cancer	2.97e-06	0.000104	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TP53—germ cell cancer	2.96e-06	0.000104	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—HRAS—germ cell cancer	2.96e-06	0.000103	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—HRAS—germ cell cancer	2.87e-06	0.000101	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—HRAS—germ cell cancer	2.83e-06	9.9e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TP53—germ cell cancer	2.73e-06	9.54e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TP53—germ cell cancer	2.68e-06	9.39e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TP53—germ cell cancer	2.68e-06	9.37e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TP53—germ cell cancer	2.67e-06	9.34e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TP53—germ cell cancer	2.66e-06	9.31e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TP53—germ cell cancer	2.63e-06	9.22e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TP53—germ cell cancer	2.63e-06	9.19e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—HRAS—germ cell cancer	2.61e-06	9.13e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—HRAS—germ cell cancer	2.57e-06	8.98e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—HRAS—germ cell cancer	2.56e-06	8.96e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—HRAS—germ cell cancer	2.55e-06	8.93e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—HRAS—germ cell cancer	2.54e-06	8.9e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—HRAS—germ cell cancer	2.52e-06	8.82e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—HRAS—germ cell cancer	2.51e-06	8.79e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TP53—germ cell cancer	2.44e-06	8.54e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—HRAS—germ cell cancer	2.33e-06	8.17e-05	CbGpPWpGaD
